Clinical Trial Update: Clofarabine or Daunorubicin Hydrochloride and Cytarabine Followed By Decitabine or Observation in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating induction therapy with Clofarabine or Daunorubicin hydrochloride plus Cytarabine, followed by Decitabine or observation, in older patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• CYTARABINE (CYTARABINE)
• Cerubidine (Daunorubicin hydrochloride)
• Clolar (Clofarabine)
• Dacogen (decitabine)

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia (M7) | Phase 3 | Status: COMPLETED | Results posted: 2023-03-09